Diaceutics (LSE:DXRX) Common Stock : £0.17 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Diaceutics Common Stock?

Diaceutics's quarterly common stock stayed the same from Jun. 2023 (£0.17 Mil) to Dec. 2023 (£0.17 Mil) and stayed the same from Dec. 2023 (£0.17 Mil) to Jun. 2024 (£0.17 Mil).

Diaceutics's annual common stock increased from Dec. 2021 (£0.17 Mil) to Dec. 2022 (£0.17 Mil) but then stayed the same from Dec. 2022 (£0.17 Mil) to Dec. 2023 (£0.17 Mil).

Diaceutics Common Stock Historical Data

The historical data trend for Diaceutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diaceutics Common Stock Chart

Diaceutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.14

0.17

Diaceutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Common Stock	Get a 7-Day Free Trial										0.17	0.17	0.17	0.17	0.17

Diaceutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Diaceutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diaceutics PLC (LSE:DXRX) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

7DC:Germany

Address

Kings Hall Health and Wellbeing Park, Dataworks, First Floor, Building Two, Antrim, Belfast, GBR, BT9 6GW

Website

https://www.diaceutics.com

Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.

Diaceutics Headlines

No Headlines